Back to Newsroom
Back to Newsroom

United Cannabis Corporation to Begin Processing Industrial Hemp

Thursday, 06 October 2016 07:00 AM

United Cannabis Corporation

Topic:

Company Will Extract Cannabidiol, Terpenes And Other Compounds For Use In Product Development

DENVER, CO / ACCESSWIRE /  October 6, 2016 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that it will begin processing industrial hemp to extract cannabinoids, terpenes and other compounds for use in its existing and future products.

Although hemp is a member of the cannabis genus, more specifically, Cannabis Sativa, the 2014 U.S. Farm Bill differentiates industrial hemp, defining it as "a plant of the genus cannabis and any part of the plant, whether growing or not, containing a delta-9 tetrahydrocannabinol ("THC") concentration of no more than three-tenths of one percent on a dry weight basis."

Since passing, nine states have established pilot programs licensing production. According to VoteHemp, approximately 12,000 acres were planted this year, primarily in Colorado, Kentucky and Tennessee.

The Colorado Department of Agriculture, overseer of the State's industry, reports 42 of 64 counties in the state currently have growers registered to cultivate industrial hemp. As reported in July 2016, there were 361 active registered land areas, with a total of 8,896 outdoor acres and 1.1 million square feet of indoor production.

Commenting on the announcement, Chad Ruby, the Company's COO stated, "We've been watching the momentum in the industrial hemp sector since 2014, when the Farm Bill passed, and it looks to us like the trends are fixed, with Colorado leading the way. Our expertise in plant genetics and extraction technologies, combined with the vast array of growers right in our backyard, makes this venture a natural evolution for United Cannabis."

Earnest Blackmon, the Company's CEO, went on to say, "Just like all cannabis plants, each cultivar of industrial hemp has its own genetic profile, with unique variations of cannabinoids, terpenes and other compounds. We decided to pursue this market because we believe the larger our portfolio of active compounds, the better our ability to offer patients and caregivers the broadest possible spectrum of therapeutic options."

About United Cannabis Corporation

The Company's Prana Bio Medicinal products provide patients a simple, safe, accurate, and easy way to mix/match cannabinoids for therapeutic purpose. These products, licensed to regulated marijuana dispensaries, are broken into 5 easy to follow categories that are available in capsules, sublingual's, and topical delivery methods. The Company uses a patent-pending infusion process utilizing select fatty acids, lipids, and specific combination of cannabis derived terpenes to increase bioavailability. Prana Bio Medicinal products are NON-GMO, ethanol free, alcohol free, glycerin free, gluten free, 100% naturally derived, chemical-free, solventless, and hypoallergenic. 

For further information, please visit www.unitedcannabis.us

Contact: [email protected] 

Phone: 303-386-7321 

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors, created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

SOURCE: United Cannabis Corporation

Topic:
Back to newsroom
Back to Newsroom
Share by: